{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:04:14Z","timestamp":1766023454544,"version":"3.48.0"},"reference-count":29,"publisher":"e-Century Publishing Corporation","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/brvi1759","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T03:47:41Z","timestamp":1740714461000},"page":"1265-1276","source":"Crossref","is-referenced-by-count":1,"title":["Factors influencing disease-free survival after radical endometrial cancer surgery: an analysis of the competitive risk prediction mode"],"prefix":"10.62347","volume":"17","author":[{"given":"Xing","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oaknin","year":"2022","unstructured":"Oaknin A, Bosse TJ, Creutzberg CL, Giornelli G, Harter P, Joly F, Lorusso D, Marth C, Makker V, Mirza MR, Ledermann JA and Colombo N; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2022; 33: 860-877.","journal-title":"Ann Oncol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/ijgc-2020-001822","article-title":"Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy","volume":"31","author":"den Heerik ASVM","year":"2021","unstructured":"van den Heerik ASVM, Horeweg N, de Boer SM, Bosse T and Creutzberg CL. Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy. Int J Gynecol Cancer 2021; 31: 594-604.","journal-title":"Int J Gynecol Cancer"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I and Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-263.","journal-title":"CA Cancer J Clin"},{"key":"ref3","unstructured":"Yin XY, Du X, Zhang C, Zhao HB and Qin HX. Analysis of the risk factors for recurrence of early low-risk endometrioid carcinoma. J Xinxiang Med Univ 2023; 40: 1078-1082."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12905-023-02513-x","article-title":"Development and validation of competitive risk model for older women with metaplastic breast cancer","volume":"23","author":"Tang","year":"2023","unstructured":"Tang J, Zhang D and Pan X. Development and validation of competitive risk model for older women with metaplastic breast cancer. BMC Womens Health 2023; 23: 374.","journal-title":"BMC Womens Health"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1073274821989316","DOI":"10.1177\/1073274821989316","article-title":"Competitive risk analysis of prognosis in patients with cecum cancer: a population-based study","volume":"28","author":"Wu","year":"2021","unstructured":"Wu W, Yang J, Li D, Huang Q, Zhao F, Feng X, Yan H and Lyu J. Competitive risk analysis of prognosis in patients with cecum cancer: a population-based study. Cancer Control 2021; 28: 1073274821989316.","journal-title":"Cancer Control"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, Reitsma JB, Kleijnen J and Mallett S. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med 2019; 170: W1-W33.","DOI":"10.7326\/M18-1377"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ygyno.2022.11.012","article-title":"Recurrence and survival in endometrioid endometrial cancer - a population-based cohort study","volume":"168","author":"&#xC5","year":"2023","unstructured":"Åkesson Å, Adok C and Dahm-Kähler P. Recurrence and survival in endometrioid endometrial cancer - a population-based cohort study. Gynecol Oncol 2023; 168: 127-134.","journal-title":"Gynecol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3390\/medicina58091256","article-title":"Conservative management of atypical endometrial hyperplasia and early endometrial cancer in childbearing age women","volume":"58","author":"Uccella","year":"2022","unstructured":"Uccella S, Zorzato PC, Dababou S, Bosco M, Torella M, Braga A, Frigerio M, Gardella B, Cianci S, Laganà AS, Franchi MP and Garzon S. Conservative management of atypical endometrial hyperplasia and early endometrial cancer in childbearing age women. Medicina (Kaunas) 2022; 58: 1256.","journal-title":"Medicina (Kaunas)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1186\/s12885-021-08466-4","article-title":"A nomogram prediction model for lymph node metastasis in endometrial cancer patients","volume":"21","author":"Wang","year":"2021","unstructured":"Wang Z, Zhang S, Ma Y, Li W, Tian J and Liu T. A nomogram prediction model for lymph node metastasis in endometrial cancer patients. BMC Cancer 2021; 21: 748.","journal-title":"BMC Cancer"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"10732748241262184","DOI":"10.1177\/10732748241262184","article-title":"Competitive risk analysis of prognosis in older adults with sigmoid colon adenocarcinoma: a population-based study","volume":"31","author":"Du","year":"2024","unstructured":"Du R, Guo J, Li J, Lyu J and Lyu L. Competitive risk analysis of prognosis in older adults with sigmoid colon adenocarcinoma: a population-based study. Cancer Control 2024; 31: 10732748241262184.","journal-title":"Cancer Control"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000521105","article-title":"Histological prognostic factors of endometrial cancer in patients with adenomyosis: a systematic review and meta-analysis","volume":"89","author":"Raffone","year":"2022","unstructured":"Raffone A, Travaglino A, Raimondo D, Maletta M, Salucci P, Santoro A, Zullo F, Zannoni GF, Casadio P, Seracchioli R and Mollo A. Histological prognostic factors of endometrial cancer in patients with adenomyosis: a systematic review and meta-analysis. Pathobiology 2022; 89: 127-134.","journal-title":"Pathobiology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ijgo.14277","article-title":"Analysis of prognostic factors in Grade 3 endometrioid type endometrial carcinoma","volume":"159","author":"EA","year":"2022","unstructured":"Sahin EA, Toprak S, Sayal HB, Ekinci T, Yılmaz E, Bakay K, Melekoğlu R, Sezgin B, Tohma YA and Şahin H. Analysis of prognostic factors in Grade 3 endometrioid type endometrial carcinoma. Int J Gynaecol Obstet 2022; 159: 719-726.","journal-title":"Int J Gynaecol Obstet"},{"key":"ref13","unstructured":"Yu XB. Study on the related factors affecting prognosis of patients with endometrial cancer after radiotherapy. J Pract Gynecol Endocrinol 2024; 11: 28-30."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1245\/s10434-020-08261-8","article-title":"Adnexal involvement in endometrial cancer: prognostic factors and implications for ovarian preservation","volume":"27","author":"Baiocchi","year":"2020","unstructured":"Baiocchi G, Clemente AG, Mantoan H, da Costa WL Jr, Bovolim G, Guimaraes APG, da Costa AABA, De Brot L and Faloppa CC. Adnexal involvement in endometrial cancer: prognostic factors and implications for ovarian preservation. Ann Surg Oncol 2020; 27: 2822-2826.","journal-title":"Ann Surg Oncol"},{"key":"ref15","unstructured":"Alemdaroglu S, Durdag GD, Baran SY, Simsek SY, Yetkinel S, Yaginc DA, Guler OC and Celik H. Prognostic factors of endometrial cancer in elderly patient group and their effects on survival. North Clin Istanb 2021; 8: 345-353."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"8199","DOI":"10.1007\/s11033-020-05760-5","article-title":"Beyond lipid-lowering: role of statins in endometrial cancer","volume":"47","author":"AMHA","year":"2020","unstructured":"Hafizz AMHA, Zin RRM, Aziz NHA, Kampan NC and Shafiee MN. Beyond lipid-lowering: role of statins in endometrial cancer. Mol Biol Rep 2020; 47: 8199-8207.","journal-title":"Mol Biol Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ygyno.2021.02.007","article-title":"Implications of the obesity epidemic for endometrial cancer risk, mortality, and survivorship","volume":"160","author":"Felix","year":"2021","unstructured":"Felix AS and Sherman ME. Implications of the obesity epidemic for endometrial cancer risk, mortality, and survivorship. Gynecol Oncol 2021; 160: 643-645.","journal-title":"Gynecol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1053\/j.gastro.2020.10.057","article-title":"Metabolism and metabolic disorders and the microbiome: the intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies","volume":"160","author":"Aron-Wisnewsky J","year":"2021","unstructured":"Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M and Clément K. Metabolism and metabolic disorders and the microbiome: the intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies. Gastroenterology 2021; 160: 573-599.","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Kokts-Porietis RL, Elmrayed S, Brenner DR and Friedenreich CM. Obesity and mortality among endometrial cancer survivors: a systematic review and meta-analysis. Obes Rev 2021; 22: e13337.","DOI":"10.1111\/obr.13337"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Kolehmainen A, Pasanen A, Tuomi T, Koivisto-Korander R, Bützow R and Loukovaara M. Clinical factors as prognostic variables among molecular subgroups of endometrial cancer. PLoS One 2020; 15: e0242733.","DOI":"10.1371\/journal.pone.0242733"},{"key":"ref21","unstructured":"Zhang H and Kong WM. Establishment of a nomogram model for predicting risk of endometrial malignant hyperplasia based on analysis of metabolic factors of patients. J Chin Oncol 2021; 27: 566-571."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3389\/fonc.2019.00744","article-title":"The role of metabolic syndrome in endometrial cancer: a review","volume":"9","author":"Yang","year":"2019","unstructured":"Yang X and Wang J. The role of metabolic syndrome in endometrial cancer: a review. Front Oncol 2019; 9: 744.","journal-title":"Front Oncol"},{"key":"ref23","unstructured":"Jiang YS, Pei LP, Li GY, Qu CH and Xu B. Analysis of factors affecting long term prognosis of patients with endometrial carcinoma. Trauma and Critical Care Medicine 2024; 12: 47-49, 54."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"21694","DOI":"10.1038\/s41598-021-01263-w","article-title":"Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma","volume":"11","author":"Quan","year":"2021","unstructured":"Quan Q, Liao Q, Yin W, Zhou S, Gong S and Mu X. Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma. Sci Rep 2021; 11: 21694.","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Erturk A, Korkmaz E, Arslantas Z, Bekdemir S and Erturk NK. Preoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer. Rev Assoc Med Bras (1992) 2024; 70: e20231115.","DOI":"10.1590\/1806-9282.20231115"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ajpath.2022.12.005","article-title":"Cancer antigen 125 expression enhances the gemcitabine\/cisplatin-resistant tumor microenvironment in bladder cancer","volume":"193","author":"Yamashita","year":"2023","unstructured":"Yamashita T, Higashi M, Sugiyama H, Morozumi M, Momose S and Tamaru JI. Cancer antigen 125 expression enhances the gemcitabine\/cisplatin-resistant tumor microenvironment in bladder cancer. Am J Pathol 2023; 193: 350-361.","journal-title":"Am J Pathol"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Cymbaluk-Płoska A, Gargulińska P, Bulsa M, Kwiatkowski S, Chudecka-Głaz A and Michalczyk K. Can the determination of HE4 and CA125 markers affect the treatment of patients with endometrial cancer? Diagnostics (Basel) 2021; 11: 626.","DOI":"10.3390\/diagnostics11040626"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.3390\/cancers13194764","article-title":"HE4 as a biomarker for endometrial cancer","volume":"13","author":"Behrouzi","year":"2021","unstructured":"Behrouzi R, Barr CE and Crosbie EJ. HE4 as a biomarker for endometrial cancer. Cancers (Basel) 2021; 13: 4764.","journal-title":"Cancers (Basel)"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/2\/ajtr0161937.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:59:27Z","timestamp":1766023167000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/2\/ajtr0161937.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/brvi1759","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}